Skip to main content

HL7 FHIR MedMorph Reference Architecture and Implementation Guide

The Health Level Seven International (HL7) Fast Healthcare Interoperability Resources (FHIR) MedMorph Reference Architecture and Implementation Guide is a technical standard that defines a FHIR-based framework for securely and consistently exchanging health data from clinical systems to public health and research organizations.

  • Framework for using HL7 FHIR to support public health and research data exchange (health data interoperability)
  • Reference architecture for trusted, standards-based workflows between clinical systems and authorized data receivers (integration architecture)
  • Profiles and guidance for representing public health use case data using FHIR resources (data modeling and profiling)
  • Security, authorization, and trust model for data exchange to public health agencies and other registries (access control and secure transport)
  • Reusable implementation patterns that can be adapted to different public health programs and reporting scenarios (implementation guidance)

More About MedMorph

The HL7 FHIR MedMorph Reference Architecture and Implementation Guide defines a standards-based approach for exchanging health data from clinical care delivery systems to public health, registries, and research organizations. It focuses on using HL7 FHIR (health data interoperability) to enable structured, automated, and reusable workflows for data submission that can be applied across multiple public health use cases.

The MedMorph specification provides a reference architecture (integration architecture) that describes how Electronic Health Record (EHR) systems and other data sources interact with intermediary services and data receivers. It documents actors, roles, and workflows for initiating data extraction, transforming content into FHIR-based representations, and securely transmitting data to public health agencies, specialty registries, or research programs. The architecture is intended to be reusable so that common components and patterns can support multiple reporting requirements.

Within the implementation guide, MedMorph defines FHIR profiles, extensions, and value sets (data modeling and profiling) tailored to public health and research reporting. These artifacts describe how to represent patient data, encounters, conditions, laboratory results, and related information in a way that aligns with public health program requirements while remaining consistent with the base FHIR specification. The guide also addresses packaging of data using FHIR Bundles and other structures suitable for bulk submission or event-based messaging.

MedMorph also covers aspects of authorization, security, and trust (access control and secure transport). The guide provides guidance on how systems authenticate, authorize, and audit data exchanges to ensure that only approved entities access protected health information. It references the use of widely adopted web security and identity mechanisms aligned with FHIR-based APIs, providing a consistent pattern for enterprise implementations.

In enterprise and institutional environments, MedMorph is used by EHR vendors, health systems, public health agencies, and registries to design interoperable interfaces and workflows (systems integration). Organizations can apply the reference architecture as a template for building services that extract data from clinical systems, transform it into FHIR-based public health payloads, and deliver it to multiple programs with minimal customization per program. This approach reduces the need for bespoke point-to-point integrations and supports standardized data sharing practices.

From a technical categorization standpoint, MedMorph fits into health data interoperability standards, public health reporting frameworks, and implementation guidance for HL7 FHIR. It provides an architectural blueprint, data definitions, and operational guidance that can be used to align enterprise health IT infrastructure with public health and research data exchange requirements.